BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

May 09, 2024 | News

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | News

FDA Approves Geneoscopy's Noninvasive Colorectal Cancer Test, ColoSense

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced that the U...

May 07, 2024 | News

ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types

The agreement aims to supply ImmunityBio with Bacillus Calmette-Guerin (BCG), a critical component in cancer treatment. Under the collaboration, the ...

May 06, 2024 | News

HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment

HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...

May 06, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

Thermo Fisher Scientific Launches Innovative Urine Test for Kidney Transplant Monitoring

For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of r...

May 03, 2024 | News

Jacobio Pharma Reports Promising Phase II Results for Glecirasib in Lung Cancer at ASCO

Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at th...

May 01, 2024 | News

AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA

AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...

April 30, 2024 | News

C₂N Diagnostics Partners with Mediford Corporation to Expand Alzheimer's Research Services in Japan

-C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a part...

April 29, 2024 | News

Fosun Pharma's Artemisinin Medicines Boost Malaria Fight in Africa

Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger health and cost lives, b...

April 29, 2024 | News

PolyU Partners with ZEISS Vision Care to Advance Global Myopia Control

The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalm...

April 26, 2024 | News

Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug

Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...

April 23, 2024 | News

Aptamer Group Ships Innovative Optimer Delivery Vehicle for Liver Disease Treatment

Optimer delivery vehicle has been shipped to a pharma partner for external evaluation The specific delivery vehicle could generate new precision t...

April 22, 2024 | News

Stay Connected